$1.010
+0.052 (+5.15%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Gain Therapeutics Inc (GANX) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting GANX is Strong sell.
Gain Therapeutics Inc (GANX) 20-Day simple moving average is 1.21, while Gain Therapeutics Inc (GANX) share price is $—, making it Sell.
Gain Therapeutics Inc (GANX) 60-Day simple moving average is 1.61, while Gain Therapeutics Inc (GANX) share price is $—, making it Sell.
Technical Analysis for GANX
AI Technical GANXAs of 2026-11-03, the technical board for Gain Therapeutics Inc (GANX) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $1.01 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 29.429, MACD stands at -0.147 (Sell), Stochastic %K stands at 10.316 (Buy), Stochastic %D stands at 8.48 and CCI stands at -150.075 (Buy).
GANX trades below the 60-day SMA (1.61) and below the 200-day SMA (1.84). Immediate resistance sits at Classic R1 1.29, then R2 1.45. Support sits at Classic S1 0.95, then S2 0.77.
Gain Therapeutics Inc (GANX) Support & Resistance Level
Gain Therapeutics Inc (GANX) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 29.429 |
| STOCHk_14_3_3 | 10.316 |
| STOCHd_14_3_3 | 8.480 |
| CCI_20 | -150.075 |
| AO_5_34 | -0.348 |
| MOM_10 | -0.230 |
| MACD_12_26_9 | -0.147 |
Gain Therapeutics Inc (GANX) Relative Strength Index (RSI_14) is 29.429, creating a Buy signal.
Gain Therapeutics Inc (GANX) Stochastic %K is 10.316, creating a Buy signal.
Gain Therapeutics Inc (GANX) Stochastic %D is 8.480, creating a Buy signal.
Gain Therapeutics Inc (GANX) CCI_20 is -150.075, creating a Buy signal.
Gain Therapeutics Inc (GANX) Awesome Oscillator (AO) is -0.348, creating a Sell signal.
Gain Therapeutics Inc (GANX) Momentum (MOM) is -0.230, creating a Sell signal.
Gain Therapeutics Inc (GANX) Moving Average Convergence Divergence (MACD) is -0.147, creating a Sell signal.
Gain Therapeutics Inc (GANX) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.076 | Sell |
| MA_10 | 1.122 | Sell |
| MA_20 | 1.214 | Sell |
| MA_60 | 1.612 | Sell |
| MA_200 | 1.838 | Sell |
| MA_250 | 2.066 | Sell |
Gain Therapeutics Inc (GANX) 5-Day simple moving average is 1.076, while Gain Therapeutics Inc (GANX) share price is $, making it a Sell.
Gain Therapeutics Inc (GANX) 10-Day simple moving average is 1.122, while Gain Therapeutics Inc (GANX) share price is $, making it a Sell.
Gain Therapeutics Inc (GANX) 20-Day simple moving average is 1.214, while Gain Therapeutics Inc (GANX) share price is $, making it a Sell.
Gain Therapeutics Inc (GANX) 60-Day simple moving average is 1.612, while Gain Therapeutics Inc (GANX) share price is $, making it a Sell.
Gain Therapeutics Inc (GANX) 200-Day simple moving average is 1.838, while Gain Therapeutics Inc (GANX) share price is $, making it a Sell.
Gain Therapeutics Inc (GANX) 250-Day simple moving average is 2.066, while Gain Therapeutics Inc (GANX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.